Exploring Comorbidity Patterns in Inflammatory Bowel Disease: Insights from the All of Us Research Program
-
By
-
Soham C. Sudhakaran
-
Matthew T. Wayland
-
Yogesh Purushotham
-
Scott B. Minchenberg
-
Kanwal Bains
-
Sudhakaran Prabakaran
-
March 14, 2026
-
Clinical Scorecard: Exploring Comorbidity Patterns in Inflammatory Bowel Disease: Insights from the All of Us Research Program
At a Glance
| Category | Detail |
|---|
| Condition | Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis |
| Key Mechanisms | Shared inflammatory pathways (IL-17/IL-23/IL-12/TNF-α), epithelial barrier dysfunction, systemic inflammation, gut-organ axis dysfunction |
| Target Population | Diverse IBD patients including historically underrepresented racial and ethnic groups |
| Care Setting | Comprehensive clinical management across multiple organ systems |
Key Highlights
- Study of 5,094 IBD patients identified 22 significant comorbidities across seven organ systems.
- Novel comorbidity associations include delayed postmyocardial infarction pericarditis, contact dermatitis, and carotid artery aneurysms.
- The All of Us Research Program provides a demographically diverse cohort addressing underrepresentation in prior IBD research.
Guideline-Based Recommendations
Diagnosis
- Use a validated two-step case definition requiring both IBD diagnostic codes and evidence of IBD-specific medication prescriptions.
- Employ comprehensive OMOP coding to capture full spectrum of IBD-related systemic manifestations.
Management
- Adopt a multisystem approach to IBD care addressing dermatologic, cardiovascular, autoimmune, and other systemic comorbidities.
- Prioritize surveillance and therapeutic strategies tailored to diverse populations and rare comorbidities.
Monitoring & Follow-up
- Monitor for comorbidities across multiple organ systems given IBD's systemic inflammatory nature.
- Incorporate longitudinal tracking of patient data to identify emerging comorbid conditions.
Risks
- Recognize increased healthcare costs and disability burden associated with IBD and its comorbidities.
- Account for demographic disparities in disease incidence and comorbidity patterns.
Patient & Prescribing Data
5,094 IBD patients identified via EHR data with diverse demographic representation.
Prescription data used to validate IBD diagnosis; highlights importance of medication evidence in case definition.
Clinical Best Practices
- Incorporate diverse demographic representation in IBD research and clinical trials to improve generalizability.
- Use systematic frameworks addressing inflammatory pathways, barrier dysfunction, systemic inflammation, and gut-organ axes in IBD management.
- Leverage large-scale, harmonized EHR datasets like All of Us for comprehensive comorbidity assessment.
References
